• Publications
  • Influence
Handbook on Injectable Drugs
In the ever-changing, data-intense, split-second decision world of parenteral drugs, that touchstone, that premier resource, is the Handbook on Injectable Drugs, 16th Edition. It is the leadingExpand
  • 501
  • 20
  • PDF
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
BACKGROUND The absence of drug compatibility information with 3-in-1 parenteral nutrition admixtures has been problematic. The purpose of this project was to evaluate the physical compatibility ofExpand
  • 76
  • 6
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
The compatibility of 102 drugs with parenteral nutrient (PN) solutions during simulated Y-site administration was studied. Five milliliters of each of four representative PN solutions was combined inExpand
  • 42
  • 4
Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection.
The compatibility of taxol in 5% dextrose injection with each of 17 other drugs during simulated Y-site injection was studied through visual and turbidimetric assessment. A 4-mL sample of taxol 1.2Expand
  • 80
  • 3
Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers.
The stability of taxol (NSC-125973) in various diluents and containers was determined, and the extent of leaching of di(2-ethylhexyl) phthalate (DEHP) from polyvinyl chloride (PVC) bags caused by theExpand
  • 117
  • 2
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
The compatibility of a new formulation of injectable propofol with selected other drugs during simulated Y-site injection was studied. Two milliliters of undiluted propofol injectable emulsion wasExpand
  • 65
  • 2
Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
PURPOSE Using a multiple-step testing medium-risk-level compounding test procedure, the evaluation of two work-practice changes to determine if the changes could effectively reduce the potential forExpand
  • 21
  • 2
  • PDF
Safety of Continuous Intrathecal Midazolam Infusion in the Sheep Model
We investigated the safety of midazolam administered by continuous intrathecal infusion in relevant animal models. Preservative-free midazolam was delivered to sheep and pigs by using implantedExpand
  • 45
  • 2
Echinomycin: The first bifunctional intercalating agent in clinical trials
SummaryEchinomycin is a quinoxaline antibiotic that was originally isolated from Streptomyces echinatus. Based on its antitumor activity against two i.p. implanted murine tumors, the B16 melanoma,Expand
  • 32
  • 2
Drug compatibility with new polyolefin infusion solution containers.
PURPOSE The compatibility of new polyolefin (VISIV) containers with seven drugs that have exhibited sorption to polyvinyl chloride (PVC) containers and sets and an additional four drugs that haveExpand
  • 20
  • 2